GDTC short interest
CytoMed Therapeutics Limited · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 17,102 |
|---|---|
| Change vs prior report | 13,482 (+372.4%) |
| Change over six months | -79.3% |
| Days to cover | 1.07 (sector: 3.78) |
| Average daily volume | 15,986 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
GDTC short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 17,102 | +372.4% | 1.07 | 15,986 |
| 2026-09-15 | 3,620 | -43.2% | 1.00 | 11,046 |
| 2026-08-31 | 6,370 | +51.4% | 1.00 | 22,519 |
| 2026-08-14 | 4,207 | -25.6% | 1.00 | 30,024 |
| 2026-07-31 | 5,655 | -81.2% | 1.00 | 329,145 |
| 2026-07-15 | 30,057 | -20.7% | 3.03 | 9,918 |
| 2026-06-30 | 37,906 | -17.6% | 2.95 | 12,850 |
| 2026-06-15 | 46,008 | -32.3% | 1.99 | 23,137 |
| 2026-05-29 | 67,963 | -4.4% | 2.27 | 29,986 |
| 2026-05-15 | 71,090 | +4.3% | 2.69 | 26,469 |
| 2026-04-30 | 68,135 | -5.3% | 11.22 | 6,072 |
| 2026-04-15 | 71,945 | -13.0% | 10.37 | 6,938 |
| 2026-03-31 | 82,681 | -29.4% | 9.98 | 8,284 |
| 2026-03-13 | 117,191 | -14.6% | 9.67 | 12,118 |
| 2026-02-27 | 137,172 | -30.6% | 4.21 | 32,592 |
| 2026-02-13 | 197,539 | +1284.3% | 1.00 | 3,303,600 |
| 2026-01-30 | 14,270 | -46.7% | 1.00 | 28,594 |
| 2026-01-15 | 26,790 | +27.3% | 1.00 | 45,218 |
| 2025-12-31 | 21,050 | -49.1% | 1.00 | 28,433 |
| 2025-12-15 | 41,345 | +50.4% | 1.00 | 52,154 |
| 2025-11-28 | 27,483 | +24.5% | 1.00 | 107,855 |
| 2025-11-14 | 22,080 | +31.3% | 1.00 | 167,345 |
| 2025-10-31 | 16,818 | -83.8% | 1.00 | 181,492 |
| 2025-10-15 | 103,710 | +264.4% | 1.00 | 177,642 |
| 2025-09-30 | 28,459 | -33.6% | 2.02 | 14,098 |
import finzdata as yf
yf.Ticker("GDTC").short_interest # every report since 2017
yf.Client().short_interest(["GDTC"], start="2018-01-01")Healthcare short interest · GDTC price history · Who owns GDTC · All short interest